These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 31723002)
1. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma. Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002 [TBL] [Abstract][Full Text] [Related]
2. Two mechanisms involving the autophagic and proteasomal pathways process the metastasis suppressor protein, N-myc downstream regulated gene 1. Sahni S; Park KC; Kovacevic Z; Richardson DR Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1361-1378. PubMed ID: 30763642 [TBL] [Abstract][Full Text] [Related]
3. Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma. Furuta T; Sabit H; Dong Y; Miyashita K; Kinoshita M; Uchiyama N; Hayashi Y; Hayashi Y; Minamoto T; Nakada M Oncotarget; 2017 Apr; 8(14):22811-22824. PubMed ID: 28423558 [TBL] [Abstract][Full Text] [Related]
4. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112 [TBL] [Abstract][Full Text] [Related]
5. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways. Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963 [TBL] [Abstract][Full Text] [Related]
6. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling. Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847 [TBL] [Abstract][Full Text] [Related]
7. N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2. Yang X; Zhu F; Yu C; Lu J; Zhang L; Lv Y; Sun J; Zheng M Oncotarget; 2017 Jul; 8(29):47709-47724. PubMed ID: 28537875 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways. Ma W; Na M; Tang C; Wang H; Lin Z Mol Med Rep; 2015 Jul; 12(1):1050-8. PubMed ID: 25777142 [TBL] [Abstract][Full Text] [Related]
9. N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM). Zhang X; Chen Q; Li Y; Chen H; Jiang Q; Hu Q Biomed Res Int; 2022; 2022():3233004. PubMed ID: 35813230 [TBL] [Abstract][Full Text] [Related]
10. Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion. Chen J; Ananthanarayanan B; Springer KS; Wolf KJ; Sheyman SM; Tran VD; Kumar S Cancer Res; 2020 Jan; 80(1):69-78. PubMed ID: 31641031 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma. Tian T; Mingyi M; Qiu X; Qiu Y Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996 [TBL] [Abstract][Full Text] [Related]
12. Nuclear GSK3β induces DNA double-strand break repair by phosphorylating 53BP1 in glioblastoma. Yang Y; Lei T; Du S; Tong R; Wang H; Yang J; Huang J; Sun M; Wang Y; Dong Z Int J Oncol; 2018 Mar; 52(3):709-720. PubMed ID: 29328365 [TBL] [Abstract][Full Text] [Related]
13. Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of its modifying kinase GSK3beta. Banz VM; Medová M; Keogh A; Furer C; Zimmer Y; Candinas D; Stroka D Biochim Biophys Acta; 2009 Oct; 1793(10):1597-603. PubMed ID: 19682504 [TBL] [Abstract][Full Text] [Related]
14. Multi-modal mechanisms of the metastasis suppressor, NDRG1: Inhibition of WNT/β-catenin signaling by stabilization of protein kinase Cα. Gholam Azad M; Hussaini M; Russell TM; Richardson V; Kaya B; Dharmasivam M; Richardson DR J Biol Chem; 2024 Jul; 300(7):107417. PubMed ID: 38815861 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]
17. Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells. Dixon KM; Lui GY; Kovacevic Z; Zhang D; Yao M; Chen Z; Dong Q; Assinder SJ; Richardson DR Br J Cancer; 2013 Feb; 108(2):409-19. PubMed ID: 23287991 [TBL] [Abstract][Full Text] [Related]
18. The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1. Narayanan A; Gagliardi F; Gallotti AL; Mazzoleni S; Cominelli M; Fagnocchi L; Pala M; Piras IS; Zordan P; Moretta N; Tratta E; Brugnara G; Altabella L; Bozzuto G; Gorombei P; Molinari A; Padua RA; Bulfone A; Politi LS; Falini A; Castellano A; Mortini P; Zippo A; Poliani PL; Galli R Cell Death Differ; 2019 Sep; 26(9):1813-1831. PubMed ID: 30538287 [TBL] [Abstract][Full Text] [Related]
19. Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma. Kitabayashi T; Dong Y; Furuta T; Sabit H; Jiapaer S; Zhang J; Zhang G; Hayashi Y; Kobayashi M; Domoto T; Minamoto T; Hirao A; Nakada M Sci Rep; 2019 Jul; 9(1):10049. PubMed ID: 31296906 [TBL] [Abstract][Full Text] [Related]
20. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation. Lu WJ; Chua MS; Wei W; So SK Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]